Moderna raises full-year COVID vaccine sales forecast to $21 billion

6 months ago 26
(Reuters) - Moderna (NASDAQ:) Inc connected Thursday raised its full-year forecast for income of its COVID-19 vaccine to astir $21 cardinal from $19 billion.

The institution successful February forecast income of $19 cardinal from its signed contracts, and enactment for $3 cardinal successful further purchases.

Moderna connected Thursday forecast further purchases of astir $500 million.

Read Entire Article